Skip to main content
. 2023 Aug 1;20(8):1077–1087. doi: 10.1513/AnnalsATS.202304-305ST

Table 4.

Disadvantages to having basic and translational scientists in clinical divisions

Disadvantages to the Clinical Unit Disadvantages to the Ph.D., Basic or Translational Scientist
  • Financial commitment to unfunded salary and start-up

  • If hiring Ph.D.s only on nontenure track, turnover is likely to be high

  • Need to hire more research administrative staff to cover added grant submissions

  • Need to obtain wet lab space (or dry lab for computational researchers) and pay institutional taxes on that space

  • Ph.D.s do not generate clinical revenue

  • Recruitment of top Ph.D. talent to basic science unit can be frustrating when basic science department offers are more attractive than clinical units leading to negative sentiment

  • Leadership may be unfamiliar with how to structure career development or promotion packages for Ph.D. faculty

  • Faculty meetings may rarely focus on topics of relevance to basic research or education

  • Clinical chiefs, directors, and chairs may be less familiar with professional development needs for promotion and tenure for basic scientists

  • Lack of access to Ph.D. and M.S. students without a joint appointment to a basic science unit or degree program

  • Sense of isolation

  • Staff in clinical unit may be less familiar with research grant submission and administration

  • Fewer leadership opportunities and tenure track options may be limited

  • Start-up packages and space norms may differ from basic science department at same academic medical center